Showing results (331-340 of 404) with videos related to
Sort By:
Pageof 41
Schweizerische Medizinische Wochenschrift|November 24, 1998
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation]A Tichelli, D Surbek, H Huxol, et al.Blood|May 15, 1992
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?M M Horowitz, D Przepiorka, R E Champlin, et al.Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.Bone Marrow Transplantation|October 17, 2003
Differences between graft product and donor side effects following bone marrow or stem cell donationG Favre, M Beksaç, A Bacigalupo, et al.Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.Bone Marrow Transplantation|August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?D Niederwieser, C Gentilini, U Hegenbart, et al.Pageof 41